Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells

产品简述

期刊
Chemistry - An Asian Journal


标题
Rational Design of Selenadiazole Derivatives to Antagonize Hyperglycemia-Induced Drug Resistance in Cancer Cells 


作者
Yuedan Liu, Yi Luo, Dr. Xiaoling Li, Dr. Wenjie Zheng and Dr. Tianfeng Chen


摘要
Se shall overcome: An effective strategy to design selenadiazole derivatives with the potency to overcome hyperglycemia-induced drug resistance in cancer cells via regulation of ROS-mediated signaling pathways is reported.


原文链接
http://onlinelibrary.wiley.com/doi/10.1002/asia.201403409/abstract


2017年02月09日

添加时间:

Synthesis and Mechanistic Study of Cyclic Oxoguanidines via Zn(OTf)2-Catalyzed Guanylation/Amidation from Readily Available Amino Acid Esters and Carbodiimides (Chem. Eur. J. 29/2015) (page 10580)

上一个:

下一个:

​Rational Design of Ruthenium Complexes Containing 2,6-Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation (ChemMedChem 6/2015) (page 934)
  • 1
本网站由阿里云提供云计算及安全服务